发明名称 |
Haloallylamine inhibitors of SSAO-VAP-1 and uses therefor |
摘要 |
The present invention is related to the preparation and pharmaceutical use of substituted 3-haloallylamine derivatives as SSAO/VAP-1 inhibitors having the structure of Formula I, as defined in the specification: Formula I The invention also relates to methods of using compounds of Formula I, or pharmaceutically acceptable salt or derivatives thereof, for the treatment of a variety of indications, e.g., inflammatory diseases, ocular diseases, fibrotic diseases, diabetes induced diseases and cancer. |
申请公布号 |
AU2013203655(B2) |
申请公布日期 |
2017.02.02 |
申请号 |
AU20130203655 |
申请日期 |
2013.04.11 |
申请人 |
Boehringer Ingelheim International GmbH |
发明人 |
Deodhar, Mandar;Findlay, Alison Dorothy;Foot, Jonathan Stuart;Jarolimek, Wolfgang;Mcdonald, Ian Alexander;Alan Robertson;Craig Ivan Turner |
分类号 |
C07C237/30;A61K31/166;A61K31/18;A61P1/16;A61P11/00;A61P13/12;A61P27/02;A61P29/00;A61P35/00;C07C311/37 |
主分类号 |
C07C237/30 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|